VOYA Investment Management
ORIC icon

VOYA Investment Management’s Oric Pharmaceuticals ORIC Stock Holding History

VOYA Investment Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Buy
11,222
+288
+3% +$3.27K ﹤0.01% 2160
2025
Q4 		$89.4K Buy
+10,934
New +$126K ﹤0.01% 2276
2025
Q3 		– Sell
-12,728
Closed -$129K – 2587
2025
Q2 		$129K Sell
12,728
-4,157
-25% -$27.9K ﹤0.01% 2426
2025
Q1 		$94.2K Sell
16,885
-1,904
-10% -$16.6K ﹤0.01% 2444
2024
Q4 		$152K Sell
18,789
-1,806
-9% -$16.6K ﹤0.01% 2474
2024
Q3 		$211K Sell
20,595
-650
-3% -$6.43K ﹤0.01% 2457
2024
Q2 		$150K Buy
21,245
+8,216
+63% +$73.5K ﹤0.01% 2562
2024
Q1 		$179K Sell
13,029
-3,428
-21% -$40.7K ﹤0.01% 2490
2023
Q4 		$151K Buy
16,457
+526
+3% +$3.8K ﹤0.01% 2656
2023
Q3 		$96.4K Hold
15,931
– – ﹤0.01% 2744
2023
Q2 		$124K Buy
+15,931
New +$90.5K ﹤0.01% 2726
2022
Q2 		– Sell
-11,955
Closed -$64K – 2857
2022
Q1 		$64K Sell
11,955
-55,238
-82% -$497K ﹤0.01% 2568
2021
Q4 		$987K Sell
67,193
-116,319
-63% -$1.81M ﹤0.01% 1553
2021
Q3 		$3.84M Buy
183,512
+30,461
+20% +$617K 0.01% 932
2021
Q2 		$2.71M Buy
153,051
+52,570
+52% +$1.15M 0.01% 1073
2021
Q1 		$2.46M Buy
100,481
+3,287
+3% +$104K 0.01% 1077
2020
Q4 		$3.29M Buy
+97,194
New +$2.79M 0.01% 951

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

VOYA Investment Management's ORIC Position: Q1 2026 in Review

VOYA Investment Management increased its Oric Pharmaceuticals (ORIC) stake by 2.6% in Q1 2026, buying an estimated $3.27K and bringing the position to 11,222 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

VOYA Investment Management first reported a position in ORIC in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.84M in Q3 2021. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • VOYA Investment Management held 11,222 shares of Oric Pharmaceuticals worth $142K as of Q1 2026.
  • VOYA Investment Management bought 288 Oric Pharmaceuticals shares in Q1 2026, an estimated $3.27K.
  • Oric Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2160 holding.
  • VOYA Investment Management first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
  • VOYA Investment Management's Oric Pharmaceuticals position peaked at $3.84M in Q3 2021.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.